Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
O. El-Shinawy, H. Makhlouf, L. Hassan, H. Rashed (Assiut, Egypt). Severe community acquired pneumonia: clinical and aetiological evaluation. Eur Respir J 2007; 30: Suppl. 51, 3916

Member's Comments

No comment yet.

Related content which might interest you: Etiologic evaluation of community acquired pneumonia Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Severe community-acquired pneumonia in China: epidemiology and clinical practice Source: International Congress 2019 – Chinese programme 2019: Part II Year: 2019 Management of severe community acquired pneumonia Source: Virtual Congress 2020 – German programme 2020 Year: 2020 Factors related to obtain an etiological diagnosis in community acquired pneumonia (CAP) Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Late-breaking abstract: The differences in clinical presentations between severe health care-associated pneumonia and severe community-acquired pneumonia: A single center experience Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Disagreement in radiological diagnosis of community acquired pneumonia and its impact on management and mortality: Is the term ’pneumonia’ outdated? Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Severe mixed community acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Diagnosis and management of community acquired pneumonia in adults Source: Virtual Congress 2020 – Clinical grand round: revisiting current guidelines Year: 2020 Characterization of community acquired pneumonia (CAP) with severe sepsis at diagnosis Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Etiology and prognosis factors in severe community acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 477s Year: 2002 Management of community acquired pneumonia audit Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Community acquired pneumonia and co-existing acute kidney injury have poor clinical outcomes Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Management of community acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Management of community acquired pneumonia Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests Year: 2008 Cytokine-based prediction of aetiology in community acquired pneumonia Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017 Contribution of clinical pulmonary infection score in the diagnosis of hospital acquired pneumonia Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Sepsis in severe community acquired pneumonias – an Indian experience Source: Eur Respir J 2006; 28: Suppl. 50, 632s Year: 2006 Clinical presentation and evolution of community acquired pneumonia in older patients Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 Viral and M. pneumoniae community acquired pneumonia and novel clinical outcome evaluation in ambulatory adult patients Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010